ID: ALA5204901
Chembl Id: CHEMBL5204901
PubChem CID: 168294504
Max Phase: Preclinical
Molecular Formula: C11H13ClFNO
Molecular Weight: 193.22
Associated Items:
Canonical SMILES: Cl.NC/C(=C/F)[C@@H]1Cc2ccccc2O1
Standard InChI: InChI=1S/C11H12FNO.ClH/c12-6-9(7-13)11-5-8-3-1-2-4-10(8)14-11;/h1-4,6,11H,5,7,13H2;1H/b9-6-;/t11-;/m0./s1
Standard InChI Key: LERSIUPHHFRESY-GLPDOFEKSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 193.22 | Molecular Weight (Monoisotopic): 193.0903 | AlogP: 1.80 | #Rotatable Bonds: 2 |
| Polar Surface Area: 35.25 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: 9.29 | CX LogP: 1.36 | CX LogD: -0.51 |
| Aromatic Rings: 1 | Heavy Atoms: 14 | QED Weighted: 0.78 | Np Likeness Score: 0.24 |
| 1. Foot JS, Buson A, Deodhar M, Findlay AD, Robertson AD, Turner CI, Yow T, Zhou W, Jarolimek W.. (2022) Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease., 74 [PMID:35973549] [10.1016/j.bmcl.2022.128942] |
Source(1):
